# YAP Therapeutics Inc — Form D

YAP Therapeutics Inc of LAGUNA HILLS, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-01-31. The offering totals $30.1M, of which $30.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-01-31
- Form: D
- Accession: 0001907867-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $30.1M
- Amount sold: $30.1M
- Investors: 6
- Date of first sale: 2022-01-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-431534

## Issuer

- Name: YAP Therapeutics Inc
- CIK: 0001907867
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 26051 MERIT CIRCLE, SUITE 102, LAGUNA HILLS, CA, 92653
- Phone: 949-348-1188

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| OLAV B BERGHEIM | Director | LAGUNA HILLS, CA |
| OLAV B BERGHEIM | Executive Officer | LAGUNA HILLS, CA |
| Andrew B Wade | Executive Officer | Laguna Hills, CA |

## More

- [CIK 1907867 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1907867&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001907867-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.